Does the Presence of Cervical Facet Tropism Affect the Response to Interlaminar Epidural Steroid Injections?
Launched by JANBUBI JANDAULYET · Nov 25, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 18-75 years, who applied to the pain medicine outpatient clinic, had axial neck and unilateral radicular extremity pain for at least 3 months, and were diagnosed with protruded disc herniation by magnetic resonance imaging were included in the study
- Exclusion Criteria:
- • Patients with systemic inflammatory disease, bleeding diathesis,history of psychiatric illness, malignancy, contrast material or local anesthetic agent allergy, cervical spinal stenosis, history of cervical ESI, or neck surgery in the last 3 months were excluded from the study
Trial Officials
Osman Hakan Gunduz, Professor
Study Director
Marmara University
About Janbubi Jandaulyet
Janbubi Jandaulyet is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and treatment modalities, the organization collaborates with leading healthcare professionals and research institutions to conduct rigorous clinical trials across various therapeutic areas. Janbubi Jandaulyet prioritizes ethical standards, regulatory compliance, and patient safety, ensuring that each trial is designed to generate reliable data that can contribute to the development of effective healthcare solutions. Through its commitment to scientific excellence and collaboration, Janbubi Jandaulyet aims to make meaningful contributions to the field of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Pendik, Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials